Limba
|
Pemigatinib is an orally active and selective inhibitor of FGFRwith IC50 of 0.4 nM, 0.5 nM, 1.2 nM and 30 nM for FGFR1, FGFR2, FGFR3 and FGFR4, respectively. Pemigatinib has the potential for cholangiocarcinoma.
Price | 10.848,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Pemigatinib is an orally active and selective inhibitor of FGFRwith IC50 of 0.4 nM, 0.5 nM, 1.2 nM and 30 nM for FGFR1, FGFR2, FGFR3 and FGFR4, respectively. Pemigatinib has the potential for cholangiocarcinoma. |